HNF1 and SREBP2 are important regulators of NPC1L1 in human liver
2010 · Journal of Lipid Research · 53 citations
https://doi.org/10.1194/jlr.m900274
C
Camilla Pramfalk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
61
Papers
1.1K
Citations
21
h-index
28
i10-index
Camilla Pramfalk is an academic researcher from Swedish Institute of International Affairs. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Cholesterol and Lipid Metabolism & Lipid metabolism and biosynthesis. The author has an h-index of 21, co-authored 52 publications.
ORCID: 0000-0003-4928-1256Papers by this author
worksHNF1α and SREBP2 are important regulators of NPC1L1 in human liver
2009 · Journal of Lipid Research · 49 citations
https://doi.org/10.1194/jlr.m900274-jlr200
Control of ACAT2 liver expression by HNF1
2005 · Journal of Lipid Research · 37 citations
https://doi.org/10.1194/jlr.m400450-jlr200
Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice
2022 · Oxford University Research Archive (ORA) (University of Oxford) · 19 citations
TG-interacting factor 1 acts as a transcriptional repressor of sterol O-acyltransferase 2
2014 · Journal of Lipid Research · 16 citations
https://doi.org/10.1194/jlr.m045922
How a single controlled use of a nicotine pouch affects the body in daily users
2026 · http://isrctn.com/ · 0 citations
https://doi.org/10.1186/isrctn61640125
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat